BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11891144)

  • 1. The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.
    Mägert HJ; Kreutzmann P; Drögemüller K; Ständker L; Adermann K; Walden M; John H; Korting HC; Forssmann WG
    Eur J Med Res; 2002 Feb; 7(2):49-56. PubMed ID: 11891144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical features, molecular biology and clinical relevance of the human 15-domain serine proteinase inhibitor LEKTI.
    Walden M; Kreutzmann P; Drögemüller K; John H; Forssmann WG; Hans-Jürgen M
    Biol Chem; 2002; 383(7-8):1139-41. PubMed ID: 12437098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LEKTI domain 15 is a functional Kazal-type proteinase inhibitor.
    Vitzithum K; Lauber T; Kreutzmann P; Schulz A; Sommerhoff CP; Rösch P; Marx UC
    Protein Expr Purif; 2008 Jan; 57(1):45-56. PubMed ID: 17936012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance.
    Mägert HJ; Kreutzmann P; Ständker L; Walden M; Drögemüller K; Forssmann WG
    Int J Biochem Cell Biol; 2002 Jun; 34(6):573-6. PubMed ID: 11943586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor.
    Kreutzmann P; Schulz A; Ständker L; Forssmann WG; Mägert HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(1):75-81. PubMed ID: 15026000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution.
    Jayakumar A; Kang Y; Henderson Y; Mitsudo K; Liu X; Briggs K; Wang M; Frederick MJ; El-Naggar AK; Bebök Z; Clayman GL
    Arch Biochem Biophys; 2005 Mar; 435(1):89-102. PubMed ID: 15680911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.
    Egelrud T; Brattsand M; Kreutzmann P; Walden M; Vitzithum K; Marx UC; Forssmann WG; Mägert HJ
    Br J Dermatol; 2005 Dec; 153(6):1200-3. PubMed ID: 16307658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.
    Jayakumar A; Kang Y; Mitsudo K; Henderson Y; Frederick MJ; Wang M; El-Naggar AK; Marx UC; Briggs K; Clayman GL
    Protein Expr Purif; 2004 May; 35(1):93-101. PubMed ID: 15039071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
    Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
    Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules.
    Shimomura Y; Sato N; Kariya N; Takatsuka S; Ito M
    Br J Dermatol; 2005 Nov; 153(5):1026-30. PubMed ID: 16225619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.
    Bitoun E; Micheloni A; Lamant L; Bonnart C; Tartaglia-Polcini A; Cobbold C; Al Saati T; Mariotti F; Mazereeuw-Hautier J; Boralevi F; Hohl D; Harper J; Bodemer C; D'Alessio M; Hovnanian A
    Hum Mol Genet; 2003 Oct; 12(19):2417-30. PubMed ID: 12915442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome.
    Ong C; O'Toole EA; Ghali L; Malone M; Smith VV; Callard R; Harper JI
    Br J Dermatol; 2004 Dec; 151(6):1253-7. PubMed ID: 15606522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene polymorphism in Netherton and common atopic disease.
    Walley AJ; Chavanas S; Moffatt MF; Esnouf RM; Ubhi B; Lawrence R; Wong K; Abecasis GR; Jones EY; Harper JI; Hovnanian A; Cookson WO
    Nat Genet; 2001 Oct; 29(2):175-8. PubMed ID: 11544479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
    Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
    J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and expression of a novel Kazal-type serine proteinase inhibitor gene from Zhikong scallop Chlamys farreri, and the inhibitory activity of its recombinant domain.
    Wang B; Zhao J; Song L; Zhang H; Wang L; Li C; Zheng P; Zhu L; Qiu L; Xing K
    Fish Shellfish Immunol; 2008 May; 24(5):629-37. PubMed ID: 18353679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Netherton syndrome: report of two Taiwanese siblings with staphylococcal scalded skin syndrome and mutation of SPINK5.
    Chao SC; Richard G; Lee JY
    Br J Dermatol; 2005 Jan; 152(1):159-65. PubMed ID: 15656819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).
    Schechter NM; Choi EJ; Wang ZM; Hanakawa Y; Stanley JR; Kang Y; Clayman GL; Jayakumar A
    Biol Chem; 2005 Nov; 386(11):1173-84. PubMed ID: 16307483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
    Raghunath M; Tontsidou L; Oji V; Aufenvenne K; Schürmeyer-Horst F; Jayakumar A; Ständer H; Smolle J; Clayman GL; Traupe H
    J Invest Dermatol; 2004 Sep; 123(3):474-83. PubMed ID: 15304086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netherton syndrome: mutation analysis of two Taiwanese families.
    Lin SP; Huang SY; Tu ME; Wu YH; Lin CY; Lin HY; Lee-Chen GJ
    Arch Dermatol Res; 2007 Jun; 299(3):145-50. PubMed ID: 17415575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate disulfide formation in Escherichia coli: overexpression and characterization of the first domain (HF6478) of the multiple Kazal-type inhibitor LEKTI.
    Lauber T; Marx UC; Schulz A; Kreutzmann P; Rösch P; Hoffmann S
    Protein Expr Purif; 2001 Jun; 22(1):108-12. PubMed ID: 11388807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.